Market Overview

UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking For Better Entry

Share:

Credit Suisse initiated coverage on Alkermes (NASDAQ: ALKS) with a Neutral rating and a $24.00 price target.

Credit Suisse said, "ALKS has an attractive long-term story, but we initiate at Neutral given the potential for a better entry point. Considering ALKS is up 21% YTD (Biotech up 7%, Pharma 4%), some 1H 2013 profit-taking and a potentially negative ALKS 5461 readout pose near-term risks. Conversely, a period of outperformance could start in 2H13 with our anticipated phase 3 success of aripiprazole lauroxil, a.k.a 9070 (2020 sales at $450MM; 70% probability of success). The 2014 dual chamber pen launch for Bydureon is also likely to be a positive inflection point for that franchise with positive readthrough to ALKS. At $20 the stock is more compelling given our near and long term views."

Alkermes closed at $22.19 on Wednesday.

Latest Ratings for ALKS

DateFirmActionFromTo
Dec 2020SVB LeerinkMaintainsMarket Perform
Oct 2020MizuhoUpgradesNeutralBuy
Sep 2020B of A SecuritiesMaintainsNeutral

View More Analyst Ratings for ALKS
View the Latest Analyst Ratings

 

Related Articles (ALKS)

View Comments and Join the Discussion!

Posted-In: Credit SuisseAnalyst Color Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
TSLAJP MorganMaintains125.0
INTCTruist SecuritiesMaintains64.0
FBTruist SecuritiesMaintains320.0
GSCitigroupMaintains370.0
AAPLCowen & Co.Maintains153.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com